FDG PET in the Diagnosis and Management of Pediatric and Adolescent Sarcomas-Reference-Cited by-同舟云学术

FDG PET in the Diagnosis and Management of Pediatric and Adolescent Sarcomas

Published:2020-12-12 Issue: Volume: Page:179-199
ISSN:
Container-title:PET/CT and PET/MR in Melanoma and Sarcoma
language:
Short-container-title:

Author:

Smitherman Andrew B.,Gold Stuart H.,Davis Ian J.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-60429-5_9

Reference87 articles.

1. American Cancer Society (ACS). Survival rates for osteosarcoma 2019. Retrieved from https://www.cancer.org/cancer/osteosarcoma/detection-diagnosis-staging/survival-rates.html

2. Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Bar-Shalom R. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer. 2007;49(7):901–5. https://doi.org/10.1002/pbc.21150.

3. Barger RL Jr, Nandalur KR. Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis. Acad Radiol. 2012;19(2):153–8. https://doi.org/10.1016/j.acra.2011.10.009.

4. Bensaid B, Giammarile F, Mognetti T, Galoisy-Guibal L, Pinson S, Drouet A, Combemale P. Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1. Ann Dermatol Venereol. 2007;134(10 Pt 1):735–41. https://doi.org/10.1016/s0151-9638(07)92528-4.

5. Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D, Eilber FC. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2009;15(8):2856–63. https://doi.org/10.1158/1078-0432.CCR-08-2537.